Ellia Tootoonchian: Connecting the Global Bleeding Disorders Community at WFH Congress
Ellia Tootoonchian, Data and Research Manager at World Federation of Hemophilia, shared World Federation of Hemophilia‘s post on LinkedIn, adding:
“Grateful for the opportunity to have been part of the WFH World Congress.
It was wonderful to connect with colleagues from around the globe, exchange ideas, collaborate, and learn from the experts.
It’s always inspiring and energizing to see how the bleeding disorders community comes together with a shared commitment to advance care globally.”
World Federation of Hemophilia shared a post on LinkedIn:
“More than 1,900 participants from 130 countries came together at WFH Congress 2026 in KualaLumpur to exchange knowledge, spark collaboration, and advance care worldwide.
Over four dynamic days, people with bleeding disorders, healthcare professionals, researchers, policymakers, and advocates united with a shared goal: improving care for people living with hemophilia and other bleeding disorder conditions.
We look forward to continuing the journey at wfhCCS in Prague in 2027 and at WFH Congress 2028 in Chicago”
Proceed to the video attached to the post.
Other articles about World Federation of Hemophilia on Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments